Cargando…
Possibility of SARS-CoV-2 Infection in the Metastatic Microenvironment of Cancer
According to a report from the World Health Organization (WHO), the mortality and disease severity induced by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are significantly higher in cancer patients than those of individuals with no known condition. Common and cancer-specific ris...
Autores principales: | Hayashi, Takuma, Sano, Kenji, Konishi, Ikuo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8929006/ https://www.ncbi.nlm.nih.gov/pubmed/35723396 http://dx.doi.org/10.3390/cimb44010017 |
Ejemplares similares
-
Pathological Evidence for Residual SARS-CoV-2 in the Micrometastatic Niche of a Patient with Ovarian Cancer
por: Hayashi, Takuma, et al.
Publicado: (2022) -
Cancer therapy with decreased SARS-CoV-2 infection rates in cancer patients
por: Hayashi, Takuma, et al.
Publicado: (2021) -
Abstract 153: Examination of the affinity of anti-SARS-CoV-2 IgA, which is mucosal immunity, for SARS-CoV-2 BA.4 variant and BA.5 variant
por: Hayashi, Takuma, et al.
Publicado: (2023) -
Noneffect of SARS-CoV-2 spike glycoprotein Y217N mutation on affinity between the virus and ACE2
por: Hayashi, Takuma, et al.
Publicado: (2021) -
Highly conserved binding region of ACE2 as a receptor for SARS-CoV-2 between humans and mammals
por: Hayashi, Takuma, et al.
Publicado: (2020)